Alterations in the secretory response of non-obese diabetic (NOD) mice to muscarinic receptor stimulation

Clinical Immunology and Immunopathology

Volumn 78, Issue 3, 1996, Pages 245-255

  Yamamoto, Hideo ^a   Sims, Nina E ^a,b   Macauley, Shawn P ^a   Nguyen, Kim Hoa T ^a   Nakagawa, Yoichi ^a,c   Humphreys Beher, Michael G ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b Marianna High School   (United States)

^c TSURUMI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARBACHOL; CYCLIC AMP; INOSITOL PHOSPHATE; MUSCARINIC RECEPTOR; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALIVA; SALIVARY GLAND; SIGNAL TRANSDUCTION; SUBMANDIBULAR GLAND;

EID: 0029912977     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0036     Document Type: Article

References (34)

1. Herrera, J. L., Lyons, M. F. II, and Johnson, L. F., Saliva: Its roles in health and disease. J. Clin. Gastroenterol. 10, 569-578, 1988.
2. Fox, P. C., Saliva composition and its importance in dental health. Compend. Cont. Educ. Dent. Suppl. 13, S456-S460, 1989.
3. Fox, R. I., and Kang, H.-I., Pathogenesis of Sjögren's syndrome. Rheumatol. Dis. Clin. North. Am. 18, 517-538, 1992.
4. Chan, E. K. L., and Andrade, L. E. C., Antinuclear antibodies in Sjögren's syndrome. Rheumatol. Dis. Clin. North Am. 18, 551-570, 1992.
5. Daniels, T. E., and Fox, P. C., Salivary and oral components of Sjögren's syndrome. Rheumatol. Dis. Clin. North Am. 18, 571-589, 1992.
6. Gottlieb, P. A., Rossini, A. A., and Mordes, J. P., Approaches to prevention and treatment of IDDM in animal models. Diabetes Care 11, Suppl. 1, 29-36, 1988.
7. Asamoto, H., Oishi, M., Azakawa, Y., and Tochino, Y., Histologic and immunologic changes in the thymus and other organs in NOD mice. In: 'Insulitis and Type 1 Diabetes' (T. Seiichiro, Y. Tochino, and K. Noraka, Eds.), pp. 62-71, Academic Press, Tokyo, 1986.
8. Hu, Y., Nakagawa, Y., Purushotham, K. R., and Humphreys-Beher, M. G., Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am. J. Physiol. 263, E607-E614, 1992.
9. Humphreys-Beher, M. G., Brinkley, L., Purushotham, K. R., Wang, P.-L., Nakagawa, Y., Dusek, D., Kerr, M., Chegini, N., and Chan, E. K. C., Characterization of antinuclear antibodies present in the serum from non obese diabetic (NOD) mice. Clin. Immunol. Immunopathol. 68, 350-356, 1993.
10. Hu, Y., Purushotham, K. R., Wang, P.-L., Dawson, R., Jr., and Humphreys-Beher, M. G., Down-regulation of β-adrenergic receptors and signal transduction response in salivary glands of NOD mice. Am. J. Physiol. 266, G433-G443, 1994.
11. Humphreys-Beher, M. G., Hu, Y., Nakagawa, Y., Wang, P.-L., and Purushotham, K. R., Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjögren's syndrome. Adv. Exp. Med. Biol. 350, 631-636, 1994.
12. Aub, D. L., and Putney, J. W., Jr., Properties of receptor-controlled inositol trisphosphate formation in parotid acinar cells. Biochem. J. 225, 263-266, 1985.
13. Inanaga, A., Habu, T., Tanaka, E., Taniguchi, T., Nishiura, T., Ishibashi, K., Naruse, S., and Abe, K., Age changes in secretory function of male and female rat parotid glands in response to methoxamine and pilocarpine. J. Dent. Res. 67, 565-573, 1988.
14. Baum, B. J., Dai, Y., Hiramatsu, Y., Horn, V. J., and Ambudkar, I. S., Signaling mechanisms that regulate saliva formation. Crit. Rev. Oral Biol. Med. 4, 379-384, 1993.
15. Watson, G. E., and Culp, D. I., Muscarinic cholinergic receptor subtypes in rat sublingual glands. Am. J. Physiol. 266, C335-C342, 1994.
16. Putney, S. W., Takemura, H., Hughs, A. R., and Horstman, D. A., How do inositol phosphates regulate calcium signalling? FASEB J. 3, 1899-1905, 1989.
17. Watson, E. L., Jacobson, K. L., DiJulio, D. H., and Fowd, F. J., Biphasic effects of carbachol on stimulated cAMP accumulation in mouse parotid acini. Am. J. Physiol. 265, C1061-C1068, 1993.
18. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 7, 248-254, 1976.
19. Bernfeld, P., Amylase, alpha and beta. Methods Enzymol. 1, 149-158, 1955.
20. Nakagawa, Y., Gammichia, J., Purushotham, K. R., Schneyer, C. A., and Humphreys-Beher, M. G., Epidermal growth factor activation of rat parotid gland adenylate cyclase and mediation by a GTP-binding regulatory protein. Biochem. Pharmacol. 42, 2333-2340, 1991.
21. Gilman, A. G., A protein binding assay for adenosine 3′:5-cyclic monophosphate. Proc. Natl. Acad. Sci. USA 647, 305-312, 1970.
22. Purushotham, K. R., Zelles, T., and Humphreys-Beher, M. G., Role of protein phosphorylation and inositol phospholipid turnover in rat parotid gland proliferation. Mol. Cell. Biochem. 102, 19-33, 1991.
23. Mohuczy-Dominiak, D., and Garg, L. C., Characterization of cholineric receptors in Madin-Darby canine kidney cells. J. Am. Soc. Nephrol. 3, 170-181, 1992.
24. Levey, A. I., Stormann, T. M., and Brann, M. R., Bacterial expression of human muscarinic receptor fusion proteins and generation of subtype-specific antisera. FEBS Lett. 275, 65-69, 1990.
25. Kerr, M., Fischer, J. E., Purushotham, K. R., Gao, D., Nakagawa, Y., Maeda, N., Ghanta, V., Hiramoto, R., Chegini, N., and Humphreys-Beher, M. G., Characterization of the synthesis and expression of the GTA-kinase from transformed and normal rodent cells. Biochim. Biophys. Acta 128, 375-387, 1994.
26. Hu, Y., and Humphreys-Beher, M. G., Decreased levels of adenylate cyclase contribute to the down-regulation of beta-adrenergic signal transduction in the salivary glands of the nonobese diabetic (NOD) mouse. Autoimmunity 21, 137-142, 1995.
27. Hausdorff, W. P., Caron, M. G., and Lefkowitz, R. J., Turning off the signal: Desensitization of β-adrenergic function. FASEB J. 4, 2881-2889, 1990.
28. Hall, H. D., and Schneyer, C. A., Functional mediation of compensatory enlargement of parotid. Cell Tissue Res. 184, 249-259, 1977.
29. Hall, H. D., and Schneyer, C. A., Neural regulation of compensatory enlargement of the parotid gland of the rat. Cell Tissue Res. 187, 147-151, 1978.
30. Jahn, R., and Soiling, H.-D., Phosphorylation of the same specific protein during amylase release evoked by β-adrenergic or cholinergic agonists in rat and mouse parotid glands. Proc. Natl. Acad. Sci. USA 78, 6903-6906, 1981.
31. Quissell, D. O., Watson, E., and Dowd, F. J., Signal transduction mechanisms involved in salivary gland regulated exocytosis. Crit. Rev. Oral Biol. Med. 3, 83-107, 1992.
32. Hilme, F., Herlitz, H., Söderström, T., and Hansson, L., Increased secretion of immunoglobulins in malignant hypertension. J. Hypertension 7, 91-95, 1989.
33. 1-adrenergic receptors in patients with malignant hypertension. Lancet 344, 1660-1663, 1994.
34. Fu, L.-X., Magnusson, Y., Bergh, C.-H., Liljequest, J. A., Wangsetin, F., Hjalmarson, Å., and Hoebeke, J., Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J. Clin. Invest. 91, 1964-1968, 1993.